This one time charge to settle claims against hernia kit hit hard, but maybe this is now old news, behind and out of the way. Managment did warn responsibly before hand and confirmed their push on innovations for responsible healthcare products to meet the future healthcare enviornment. Still in the right spot for aging population and showing strong international performance. This seems like a big over sell but there has been a big run up in the past 12 months and maybe a good excuss to cash in some profits, 93% institutional ownership - these big guys moving money. Might take a while to come back but looks to me like the rout is over.